HIV Drug Buyers Rip Gilead's Dismissal Bid As 'Nothing New'
By Dorothy Atkins · February 10, 2023, 6:49 PM EST
A proposed class of consumers slammed Gilead Sciences Inc.'s latest bid to end litigation accusing the biopharmaceutical company of paying off generic HIV drugmakers to delay market entry, telling a California...
To view the full article, register now.